Today: 30 June 2026
Keppel stock slips to S$10.93 as SGX shuts for weekend; Feb. 5 earnings in focus
1 February 2026
1 min read

Keppel stock slips to S$10.93 as SGX shuts for weekend; Feb. 5 earnings in focus

Singapore, Feb 1, 2026, 15:02 (SGT) — Market closed.

  • Keppel ended the day at S$10.93, slipping 1.35% ahead of the weekend.
  • The group will release its second-half and full-year 2025 results ahead of the market open on Feb. 5.
  • Keppel DC REIT’s recent results have refocused attention on data-centre and AI-driven demand.

Keppel Ltd shares closed Friday 1.35% lower at S$10.93, with roughly 4.4 million shares changing hands as investors positioned themselves ahead of next week’s earnings report.

The mood stayed cautious. Singapore’s Straits Times Index dipped 0.5% to 4,905.13 on Friday, weighed down by banks following Wall Street’s overnight slide. Private banking group LGT described the region as “mostly lower” amid a shift toward risk aversion. The Business Times

Keppel will release its second-half and full-year 2025 financial results before the market opens on Feb. 5, according to a filing with the Singapore Exchange. The notice also set Feb. 3 for Keppel Pacific Oak US REIT’s results and Feb. 4 for Keppel REIT’s.

Keppel DC REIT has already released its numbers. On Friday, it reported a 9.8% jump in FY2025 distribution per unit (DPU) to 10.381 cents, highlighting strong demand from hyperscale data centers and AI applications as growth drivers. Loh Hwee Long attributed the trust’s solid results to “strategic acquisitions” and active portfolio management.

The key for Keppel’s stock now is whether next week’s results and guidance can steer attention toward fees, recurring income, and its digital connectivity and infrastructure pipeline—rather than the wider risk sentiment.

Traders are also on the lookout for clues about capital recycling and cash returns. Such signals can quickly shift sentiment, especially when the tape is jittery.

That said, the setup works both ways. A weaker profit report, sluggish deal activity, or a guarded outlook on new investments could put the stock at risk—particularly if global markets remain unsettled over rate moves and ongoing debates about big-tech spending.

Monday’s session brings the first glimpse of positioning following the weekend. The key focus remains on Feb. 5, when Keppel is set to release results ahead of the market open.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • SELLAS Life Sciences (NASDAQ:SLS) Drops 7.77% After 8-K Filing Ahead of REGAL Data
    June 30, 2026, 10:28 AM EDT. SELLAS Life Sciences shares dropped 7.77% to $14.25 on Tuesday after an 8-K showing senior management agreements and as the market waits for Phase 3 REGAL data on galinpepimut-S in AML. The study is approaching a milestone with 78 of 80 survival events, making some investors cautious. The stock recently hit a 52-week high of $15.67, but resistance is holding there with support at the 20-day simple moving average around $8.87. Technicals are flashing overbought with the RSI at 85.19, which could mean sharper pullbacks. SELLAS works on cancer therapies including GPS and CDK9 drugs, tying its shares to updates around leadership moves and clinical trials.
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
Previous Story

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday
Next Story

Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday

Go toTop